MedTrace Logo

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

NCT05107960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2025-09-10

Study results available
· View outcomes & findings →

Summary

The main aim of this study is to check for side effects from treatment with azilsartan and how well azilsartan controls blood pressure in children from 6 to less than 16 years old with high blood pressure.

The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study.

During the study, participants with high blood pressure will take azilsartan tablets or azilsartan granules once a day according to their clinic's standard practice. The study doctors will check for side effects from azilsartan for up to 12 months after treatment starts.

Conditions

Interventions

DRUG

Azilsartan (TAK-536)

Azilsartan Tablets, Azilsartan Granules

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-16
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05107960 on ClinicalTrials.gov